Elizabeth Budde
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Elizabeth Budde as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:23 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05370430 · BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHLPeproMene Bio, Inc. · recruiting · Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma · study chair
- Ph1/Ph2NCT04329728 · The OPAL Study: AVM0703 for Treatment of Lymphoid MalignanciesAVM Biotechnology Inc · recruiting · Lymphoid Malignancies · principal investigator
- Ph1NCT03440567 · Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell LymphomaCity of Hope Medical Center · completed · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma · principal investigator
- Ph1NCT02051257 · Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin LymphomaCity of Hope Medical Center · active not recruiting · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma · principal investigator
- Ph1NCT01815749 · Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin LymphomaCity of Hope Medical Center · active not recruiting · Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Biostatistics and Research Informatics CoreP50CA107399 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Joycelynne M. Palmer · fiscal years 2004 to 2022Named on NCT02051257, NCT01815749
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:23 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Does an Early and Aggressive Combined Wrapping and Dangling Procedure Affect the Clinical Outcome of Lower Extremity Free Flaps?-A Randomized Controlled Prospective Study Using Microdialysis Monitoring.J Reconstr Microsurg · 201622 citationsRCR 1.9
- Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.Haematologica · 202420 citationsRCR 2.3
- Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.Biol Blood Marrow Transplant · 20197 citationsRCR 0.3